Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of … – PR Newswire (press release)
|
Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of …
PR Newswire (press release) BEDFORD, Mass., May 18, 2018 /PRNewswire/ — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the presentation of data from its gene therapy and gene editing programs at the 21st Annual Meeting of the … |
